Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Restricted Stock (Details)

v3.23.1
Stockholders' Equity - Restricted Stock (Details) - Restricted Stock
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Stockholders' Equity  
Non-vested beginning balance | shares 378,897
Number of Shares, Granted | shares 958,800
Number of Shares, Forfeited | shares (4,350)
Number of Shares, Vested | shares (82,275)
Non-vested ending balance | shares 1,251,072
Weighted Average Exercise Price, beginning balance | $ / shares $ 26.15
Weighted Average Grant Date Fair Value, Granted | $ / shares 2.25
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 26.29
Weighted Average Grant Date Fair Value, Vested | $ / shares 26.73
Weighted Average Exercise Price , ending balance | $ / shares $ 7.79